Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?

Medical Journal of Australia

Volumn 196, Issue 1, 2012, Pages 16-

  Roder, David M ^a   Olver, Ian N ^b  

^a Cancer Australia   (Australia)

^b CANCER COUNCIL AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; CANCER THERAPY; DIAGNOSTIC ERROR; HUMAN; MAMMOGRAPHY; OVERDIAGNOSIS; RISK BENEFIT ANALYSIS; RISK FACTOR;

AUSTRALIA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSTIC ERRORS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MORBIDITY; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SURVIVAL RATE; UNNECESSARY PROCEDURES;

EID: 84857827076     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.11466     Document Type: Article

References (5)

1. Burton RC, Bell RJ, Thiagarajah G, Stevenson C. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat 2011; 29 Sep [Epub ahead of print].
2. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353: 1784-1792.
3. Roder D. Impact of population screening programs on cancer outcomes. Cancer Forum 2011. In press.
4. World Health Organization; International Agency for Research on Cancer. IARC handbooks of cancer prevention. Vol. 7: Breast cancer screening. Lyon: IARC Press, 2002.
5. Glasziou P, Houssami N. The evidence base for breast cancer screening. Prev Med 2011; 2 Jun [Epub ahead of print].